These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30223427)

  • 1. The Effect of Long-Term Administration of Fatty Acid Amide Hydrolase Inhibitor URB597 on Oxidative Metabolism in the Heart of Rats with Primary and Secondary Hypertension.
    Biernacki M; Łuczaj W; Jarocka-Karpowicz I; Ambrożewicz E; Toczek M; Skrzydlewska E
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30223427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
    Biernacki M; Łuczaj W; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
    Toxicol Appl Pharmacol; 2016 Jun; 301():31-41. PubMed ID: 27086176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox system and phospholipid metabolism in the kidney of hypertensive rats after FAAH inhibitor URB597 administration.
    Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Bielawska K; Skrzydlewska E
    Redox Biol; 2018 May; 15():41-50. PubMed ID: 29197803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term administration of fatty acid amide hydrolase inhibitor (URB597) to rats with spontaneous hypertension disturbs liver redox balance and phospholipid metabolism.
    Biernacki M; Ambrożewicz E; Gęgotek A; Toczek M; Skrzydlewska E
    Adv Med Sci; 2019 Mar; 64(1):15-23. PubMed ID: 30243113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FAAH Inhibitor URB597 Modulates Lipid Mediators in the Brain of Rats with Spontaneous Hypertension.
    Biernacki M; Baranowska-Kuczko M; Niklińska GN; Skrzydlewska E
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32664225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.
    Pędzińska-Betiuk A; Weresa J; Toczek M; Baranowska-Kuczko M; Kasacka I; Harasim-Symbor E; Malinowska B
    Br J Pharmacol; 2017 Jul; 174(13):2114-2129. PubMed ID: 28437860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-specific influences of chronic administration of the fatty acid amide hydrolase inhibitor URB597 on cardiovascular parameters and organ hypertrophy in DOCA-salt hypertensive rats.
    Toczek M; Baranowska-Kuczko M; Grzęda E; Pędzińska-Betiuk A; Weresa J; Malinowska B
    Pharmacol Rep; 2016 Apr; 68(2):363-9. PubMed ID: 26922540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension and chronic inhibition of endocannabinoid degradation modify the endocannabinoid system and redox balance in rat heart and plasma.
    Biernacki M; Malinowska B; Timoszuk M; Toczek M; Jastrząb A; Remiszewski P; Skrzydlewska E
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():54-63. PubMed ID: 30201316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
    Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in physicochemical properties of kidney cells membrane as a consequence of hypertension and treatment of hypertensive rats with FAAH inhibitor.
    Dobrzyńska I; Szachowicz-Petelska B; Weresa J; Figaszewski ZA; Skrzydlewska E
    Chem Biol Interact; 2019 Feb; 299():52-58. PubMed ID: 30502333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypertension and FAAH inhibitor treatment of rats with primary and secondary hypertension considering the physicochemical properties of erythrocytes.
    Dobrzyńska I; Szachowicz-Petelska B; Pędzińska-Betiuk A; Figaszewski ZA; Skrzydlewska E
    Toxicol Mech Methods; 2020 May; 30(4):297-305. PubMed ID: 32028814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.
    Baranowska-Kuczko M; Kozłowska H; Kloza M; Harasim-Symbor E; Biernacki M; Kasacka I; Malinowska B
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of DOCA-salt hypertension and chronic administration of the FAAH inhibitor URB597 on K
    Kloza M; Baranowska-Kuczko M; Malinowska B; Karpińska O; Harasim-Symbor E; Kasacka I; Kozłowska H
    Vascul Pharmacol; 2017 Dec; 99():65-73. PubMed ID: 29038048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Endocannabinoid System Affects Myocardial Glucose Metabolism in the DOCA-Salt Model of Hypertension.
    Polak A; Harasim-Symbor E; Malinowska B; Kasacka I; Lewandowska A; Chabowski A
    Cell Physiol Biochem; 2018; 46(2):727-739. PubMed ID: 29621749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of chronic FAAH inhibition on myocardial lipid metabolism in normotensive and DOCA-salt hypertensive rats.
    Polak A; Harasim-Symbor E; Malinowska B; Kasacka I; Pędzińska-Betiuk A; Weresa J; Chabowski A
    Life Sci; 2017 Aug; 183():1-10. PubMed ID: 28633967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid amide hydrolase inhibitor (URB597) as a regulator of myocardial lipid metabolism in spontaneously hypertensive rats.
    Harasim-Symbor E; Polak A; Pędzińska-Betiuk A; Weresa J; Malinowska B; Lewandowska A; Kasacka I; Chabowski A
    Chem Phys Lipids; 2019 Jan; 218():141-148. PubMed ID: 30578756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Cannabidiol Administration Fails to Diminish Blood Pressure in Rats with Primary and Secondary Hypertension Despite Its Effects on Cardiac and Plasma Endocannabinoid System, Oxidative Stress and Lipid Metabolism.
    Remiszewski P; Jarocka-Karpowicz I; Biernacki M; Jastrząb A; Schlicker E; Toczek M; Harasim-Symbor E; Pędzińska-Betiuk A; Malinowska B
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
    Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
    Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.
    Li H; Wood JT; Whitten KM; Vadivel SK; Seng S; Makriyannis A; Avraham HK
    Br J Pharmacol; 2013 Oct; 170(3):489-505. PubMed ID: 23347118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
    Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
    Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.